Lenalidomide is a treatment for myeloma and blood disorders called myelodysplastic syndromes.
|US Brand Name:||Revlimid|
|Indian Brand Name:||Lenalid|
Lenalidomide is used in the treatment of multiple myeloma and lepra reaction. It has an effect on a variety of biological pathways in the cell. At present, celgene is still evaluating the hematology and oncology of this product, including multiple myeloma (MM),myelodysplastic syndrome (MDS), chronic lymphocytic leukemia and solid tumors. Myelodysplastic syndrome is a malignant blood disease with approximately 300,000 patients worldwide. Myelodysplastic syndromes occur when blood cells in the bone marrow are always at an immature stage and fail to perform their necessary functions. The bone marrow is filled with these immature cells, inhibiting the development of normal cells.
Only logged in customers who have purchased this product may leave a review.
© 2015 Copyright by CancerCareMeds